Product description
Our R&D Center has selected powerful probiotic strains (Bifidobacterium animalis subsp. lactis CP-9, Lactobacillus johnsonii MH-68, and Lactobacillus salivarius AP-32) known for their effective blood sugar control in type 1 diabetes. Studies have shown that Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 protect β-cells, stabilize blood sugar, and improve liver and kidney functions affected by diabetes.
Clinical research demonstrates that PRONULIFE®GlukoSolu probiotics improve glycated hemoglobin levels, stabilize blood sugar, reduce inflammatory hormones, and enhance anti-inflammatory hormones. NGS analysis reveals increased abundance of beneficial gut bacteria.
*For probiotics targeting type 2 diabetes, please contact us.
→ See More: https://lihi.cc/r6P71/IIN_GlukoSolu
Read more